Skip to content
1887

Abstract

Carbapenem-resistant hypervirulent (CR-hvKP) is an emerging pathogen associated with severe clinical outcomes, prompting an urgent investigation into its genomic characteristics and pathogenic potential.

We hypothesize that CR-hvKP strains exhibit high-level resistance and high virulence, leading to their rapid spread in clinical settings and posing a serious threat to clinical treatment.

The aim of the study was to investigate the phenotype and genotype of CR-hvKP strains, reveal their resistance- and virulence-related genomic characteristics and elucidate the biological characteristics of high-virulence and high-resistance strains to provide molecular epidemiological data for clinical use.

Carbapenem-resistant (CRKP) strains were obtained from clinical samples, from January 2013 to December 2018. PCR amplification was conducted to screen for carbapenem genes. To evaluate the virulence potential of the isolates, we conducted various tests, including a string test, Galleria mellonella larvae infection test, capsular polysaccharide synthesis genotyping and genetic sequencing analyses. We used PFGE, multilocus sequence typing and next-generation sequencing to detect the genetic relationship and homology of the strains.

In this study, we obtained 500 strains of CRKP, among which 18 strains were identified as CR-hvKP. All CR-hvKP strains were multidrug-resistant, exhibiting high-level resistance to most -lactam antibiotics, including carbapenems. All CR-hvKP strains except N5 were positive for KPC-2, of which 14 isolates belonged to capsular serotype K64. Ten unrelated PFGE types were identified by PFGE analysis. Based on the results of PFGE, a total of 12 CR-hvKP isolates were selected from the 18 isolates for further testing, and 9 isolates had high homology with pLVPK virulence-related plasmids. All CR-hvKP strains showed high virulence in the Galleria mellonella infection model.

The study revealed the resistance- and virulence-related genomic characteristics of CR-hvKP strains and confirmed the high virulence of these strains. These results are of great significance for understanding the epidemiological characteristics and clinical treatment of CR-hvKP and provide basic data for the formulation of corresponding prevention and control strategies.

Funding
This study was supported by the:
  • Changhai Hospital's 14th Five Year Plan (Award GH145-24)
    • Principal Award Recipient: QinQin
  • Youth Startup Fund of the First Affiliated Hospital of Naval Medical University (Award 2020QNB12)
    • Principal Award Recipient: MaWei
  • National Key Project (Award 2018YFC2000204)
    • Principal Award Recipient: QinQin
  • Biosafety Research Special Project (Award 19SWAQ06)
    • Principal Award Recipient: QinQin
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001960
2025-03-05
2026-03-09

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/3/jmm001960.html?itemId=/content/journal/jmm/10.1099/jmm.0.001960&mimeType=html&fmt=ahah

References

  1. Reid CB, Steele L, Pasquill K, Parfitt EC, Laupland KB. Occurrence and determinants of Klebsiella species bloodstream infection in the western interior of British Columbia, Canada. BMC Infect Dis 2019; 19:1070 [View Article] [PubMed]
    [Google Scholar]
  2. Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis 2015; 2:fv050 [View Article] [PubMed]
    [Google Scholar]
  3. Lee C-R, Lee JH, Park KS, Kim YB, Jeong BC et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 2016; 7: [View Article]
    [Google Scholar]
  4. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151–1161 [View Article]
    [Google Scholar]
  5. Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A et al. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzingβ-lactamase KPC-2. Antimicrob Agents Chemother 2003; 47:3881–3889 [View Article]
    [Google Scholar]
  6. Zhang R, Liu L, Zhou H, Chan EW, Li J et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 2017; 19:98–106 [View Article] [PubMed]
    [Google Scholar]
  7. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 2014; 22:686–696 [View Article] [PubMed]
    [Google Scholar]
  8. Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 1986; 146:1913–1916 [PubMed]
    [Google Scholar]
  9. Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 2012; 12:881–887 [View Article] [PubMed]
    [Google Scholar]
  10. Maruno T, Ooiwa Y, Takahashi K, Kodama Y, Takakura S et al. A liver abscess deprived a healthy adult of eyesight: endogenous endophthalmitis associated with a pyogenic liver abscess caused by serotype K1 Klebsiella Pneumonia. Intern Med 2013; 52:919–922 [View Article] [PubMed]
    [Google Scholar]
  11. Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM et al. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 2016; 16:e190–e195 [View Article] [PubMed]
    [Google Scholar]
  12. Ko W-C, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160–166 [View Article]
    [Google Scholar]
  13. Fang C-T, Lai S-Y, Yi W-C, Hsueh P-R, Liu K-L et al. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007; 45:284–293 [View Article] [PubMed]
    [Google Scholar]
  14. Gu D, Dong N, Zheng Z, Lin D, Huang M et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018; 18:37–46 [View Article] [PubMed]
    [Google Scholar]
  15. Li J, Ren J, Wang W, Wang G, Gu G et al. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections. Eur J Clin Microbiol Infect Dis 2018; 37:679–689 [View Article]
    [Google Scholar]
  16. Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 2013; 4:107–118 [View Article] [PubMed]
    [Google Scholar]
  17. Chen L, Kreiswirth BN. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis 2018; 18:2–3 [View Article] [PubMed]
    [Google Scholar]
  18. Wozniak JE, Band VI, Conley AB, Rishishwar L, Burd EM et al. A nationwide screen of carbapenem-resistant Klebsiella pneumoniae reveals an isolate with enhanced virulence and clinically undetected colistin heteroresistance. Antimicrob Agents Chemother 2019; 63:10 [View Article] [PubMed]
    [Google Scholar]
  19. Karlsson M, Stanton RA, Ansari U, McAllister G, Chan MY et al. Identification of a carbapenemase-producing hypervirulent Klebsiella pneumoniae isolate in the United States. Antimicrob Agents Chemother 2019; 63:10 [View Article]
    [Google Scholar]
  20. Bean DC, Agarwal A, Cherian BP, Wareham DW. Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: genomic and phenotypic analysis. J Glob Antimicrob Resist 2019; 17:1–2 [View Article] [PubMed]
    [Google Scholar]
  21. Lam MMC, Wyres KL, Wick RR, Judd LM, Fostervold A et al. Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15. J Antimicrob Chemother 2019; 74:1218–1222 [View Article]
    [Google Scholar]
  22. Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 2016; 80:629–661 [View Article] [PubMed]
    [Google Scholar]
  23. Lee C-R, Lee JH, Park KS, Jeon JH, Kim YB et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol 2017; 7:483 [View Article]
    [Google Scholar]
  24. Harada S, Ishii Y, Saga T, Aoki K, Tateda K. Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan. Diagn Microbiol Infect Dis 2018; 91:354–359 [View Article] [PubMed]
    [Google Scholar]
  25. Guo Y, Wang S, Zhan L, Jin Y, Duan J et al. Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. Front Cell Infect Microbiol 2017; 7:24 [View Article] [PubMed]
    [Google Scholar]
  26. Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 1986; 54:603–608 [View Article] [PubMed]
    [Google Scholar]
  27. Nassif X, Fournier JM, Arondel J, Sansonetti PJ. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 1989; 57:546–552 [View Article] [PubMed]
    [Google Scholar]
  28. Chen Y-T, Chang H-Y, Lai Y-C, Pan C-C, Tsai S-F et al. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 2004; 337:189–198 [View Article]
    [Google Scholar]
  29. Wu M-C, Lin T-L, Hsieh P-F, Yang H-C, Wang J-T. Isolation of genes involved in biofilm formation of a Klebsiella pneumoniae strain causing pyogenic liver abscess. PLoS One 2011; 6:e23500 [View Article]
    [Google Scholar]
  30. Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G. Colibactin: more than a new bacterial toxin. Toxins 2018; 10:151 [View Article] [PubMed]
    [Google Scholar]
  31. Russo TA, Olson R, Fang C-T, Stoesser N, Miller M et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 2018; 56:10 [View Article] [PubMed]
    [Google Scholar]
  32. Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist 2021; 25:26–34 [View Article] [PubMed]
    [Google Scholar]
  33. CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100, 29th ed Wayne, PA: Clinical and Laboratory Standards Institute; 2019
    [Google Scholar]
  34. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70:119–123 [View Article] [PubMed]
    [Google Scholar]
  35. Yang J, Ye L, Guo L, Zhao Q, Chen R et al. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect 2013; 19:E509–15 [View Article] [PubMed]
    [Google Scholar]
  36. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233–2239 [View Article]
    [Google Scholar]
  37. Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43:4178–4182 [View Article] [PubMed]
    [Google Scholar]
  38. Yu F, Lv J, Niu S, Du H, Tang Y-W et al. Multiplex PCR analysis for rapid detection of Klebsiella pneumoniae carbapenem-resistant (sequence type 258 [ST258] and ST11) and hypervirulent (ST23, ST65, ST86, and ST375) strains. J Clin Microbiol 2018; 56:10 [View Article] [PubMed]
    [Google Scholar]
  39. Dong N, Zhang R, Liu L, Li R, Lin D et al. Genome analysis of clinical multilocus sequence Type 11 Klebsiella pneumoniae from China. Microb Genom 2018; 4:e000149 [View Article] [PubMed]
    [Google Scholar]
  40. Insua JL, Llobet E, Moranta D, Pérez-Gutiérrez C, Tomás A et al. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect Immun 2013; 81:3552–3565 [View Article] [PubMed]
    [Google Scholar]
  41. Huntemann M, Ivanova NN, Mavromatis K, Tripp HJ, Paez-Espino D et al. The standard operating procedure of the DOE-JGI microbial genome annotation pipeline (MGAP v.4). Stand Genomic Sci 2015; 10:86 [View Article] [PubMed]
    [Google Scholar]
  42. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67:2640–2644 [View Article] [PubMed]
    [Google Scholar]
  43. Chen L, Yang J, Yu J, Yao Z, Sun L et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res 2005; 33:D325–8 [View Article] [PubMed]
    [Google Scholar]
  44. Alikhan N-F, Petty NK, Ben Zakour NL, Beatson SA. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genom 2011; 12:1–10 [View Article]
    [Google Scholar]
  45. Hennequin C, Robin F. Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 2016; 35:333–341 [View Article]
    [Google Scholar]
  46. Yang Q, Jia X, Zhou M, Zhang H, Yang W et al. Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from China: a molecular, biological, and epidemiological study. Emerg Microbes Infect 2020; 9:320–331 [View Article]
    [Google Scholar]
  47. Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors molecular epidemiology and latest updates in treatment options. Antibiotics 2023234 [View Article]
    [Google Scholar]
  48. Liu C-W, Chen Q, Ding N, Hu L-F. Ceftazidime-avibactam: combination therapy versus monotherapy in the challenge of pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. Heliyon 2024; 10:e35757 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001960
Loading
/content/journal/jmm/10.1099/jmm.0.001960
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error